Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration - Concepedia

Concepedia

Publication | Closed Access

Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration

69

Citations

7

References

2002

Year

Ch. Dittrich, G. Greim, Markus Borner, K. Weigang-Köhler, Holger Huisman, A. Amelsberg, Andreas Ehret, J. Wanders, Axel‐R. Hanauske, P. Fumoleau

European Journal of Cancer

PharmacologyPharmacokinetic StudyFibroblast Growth FactorPharmacotherapyBibx 1382Medicine

References

	Year	Citations

Page 1